Skip to content

Clinical Study of Jinfeng Pill and Letrozole Combination Therapy for PCOS-Related Infertility

Clinical Study of Jinfeng Pill and Letrozole Combination Therapy for PCOS-Related Infertility

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117547
Enrollment
Unknown
Registered
2026-01-26
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility in patients with Polycystic Ovary Syndrome

Interventions

Control Group:Placebo+Letrozole
Combination Treatment Group:Placebo+Jinfeng Pill+Letrozole
Pre-treatment Group:Jinfeng Pill+Letrozole

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 20-35; 2. Meet the diagnostic criteria for PCOS-related infertility; 3. Have a desire to conceive; 4. Have a partner with normal semen analysis; 5. Willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Individuals who are infertile due to congenital physiological defects or malformations; 2. Individuals who are infertile due to genetic factors; 3. Individuals who are infertile due to tubal factors, endometriosis, adenomyosis, uterine fibroids, uterine developmental abnormalities, combined ovarian tumors, or non-physiological cysts confirmed by examination; 4. Abnormal reproductive function in the spouse; 5. Patients with severe primary diseases of the cardiovascular, liver, kidney, or hematopoietic systems, or psychiatric disorders; 6. Individuals who have used hormones or other related or antagonistic drugs within the past 3 months, making it difficult to assess drug efficacy; 7. Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Clinical Pregnancy Rate;

Secondary

MeasureTime frame
Age;Height;Weight;Body Mass Index;Duration of Infertility;Follicle-Stimulating Hormone;Luteinizing Hormone;Estradiol;Progesterone;Total Testosterone;Anti-Müllerian Hormone;Fasting Plasma Glucose;Fasting Insulin;Homeostatic Model Assessment for Insulin Resistance;Live Birth Rate;Ovulation Rate;Spontaneous Abortion Rate;Ectopic Pregnancy Rate;Multiple Pregnancy Rate;C-Reactive Protein;Interleukin-6;Interleukin-18;D-dimer;Glycated Hemoglobin ;Triglycerides;Total Cholesterol;Low-Density Lipoprotein Cholesterol;High-Density Lipoprotein Cholesterol;

Countries

China

Contacts

Public ContactQian Zhou

Shanghai First Maternity and Infant Hospital

shzhouqian@126.com+86 133 0176 2658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026